Admescope Email Format
Biotechnology ResearchCentral Finland, Finland11-50 Employees
Admescope is a contract research organization focused on ADME-Tox science to support drug discovery for the pharmaceutical, biotechnology, and veterinary industries. Its capabilities span in vitro and in vivo drug metabolism, metabolite profiling and identification, drug–drug interactions, and quantitative bioanalysis, with an emphasis on tailoring studies to the specific compounds and project stage rather than applying generic protocols. The firm provides integrated study consulting designed to help clients design studies that meet their needs while ensuring the resulting data are interpretable and meaningful. Based in Central Finland, Admescope operates as a specialized CRO within the biotechnology research sector. Since 2020 it has been part of the Symeres organization, which expands its reach to integrated medicinal chemistry and drug discovery services through a broader platform.